Chemoprophylaxis refers to the use of chemical agents, such as drugs or medications, to prevent the development or spread of infectious diseases. This proactive approach is often employed in situations where the risk of infection is high, such as during outbreaks or in specific populations with increased vulnerability. Common examples of chemoprophylaxis include the use of antibiotics to prevent bacterial infections, antimalarial drugs for travelers visiting regions with malaria, and antiviral medications for preventing certain viral infections. The choice of the chemoprophylactic agent depends on the specific pathogen and the characteristics of the population at risk. Chemoprophylaxis is widely utilized in public health strategies, such as in the prevention of sexually transmitted infections, tuberculosis, and certain parasitic diseases. The effectiveness of chemoprophylaxis relies on factors like the timing of administration, compliance with the prescribed regimen, and the emergence of drug resistance. While chemoprophylaxis is a valuable tool in disease prevention, its use requires careful consideration of factors such as potential side effects, the development of resistance, and the overall impact on public health. Proper education, monitoring, and adherence to guidelines are crucial for the success of chemoprophylaxis programs.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom